BioPlex™ 2200 multiplexed system: Simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Antibodies for double-stranded DNA (anti-dsDNA) and chromatin represent specific markers of systemic lupus erythematosus (SLE). AIMS: (1) To evaluate the analytical performance of a multiplexed bead assay (BioPlex 2200) for the simultaneous detection of anti-dsDNA and anti-chromatin antibodies, (2) to compare the results for anti-dsDNA with those obtained using Farr assay, and (3) to analyze the clinical relevance of these antibodies when applied to the follow-up of SLE patients with active nephritis. PATIENTS AND METHODS: Hundred and five clinically characterized SLE patients and 96 healthy blood donors sera were analyzed by BioPlex 2200. RESULTS: Prevalence of these antibodies was significantly higher (p < 0.0001) in SLE patients than in controls (68 and 70% for anti-dsDNA and anti-chromatin, vs. 1% for both anti-dsDNA and anti-chromatin, respectively). If you consider a sample positive if either anti-dsDNA and/or anti-chromatin is positive, then the prevalence of these antibodies reached 78% (82/105) in SLE patients. For anti-dsDNA measurements, the kappa coefficient was 0.59 between BioPlex 2200 and Farr assay. Comparison between SLE patients with and without nephritis in a follow-up study showed that patients with active nephritis were associated with an increase of anti-dsDNA and anti-chromatin levels and a reduction of CH50, whereas no variation of antibody levels was observed in SLE patients without nephritis. CONCLUSION: Our results demonstrated a benefit of simultaneously measuring anti-dsDNA and anti-chromatin in SLE patients. The BioPlex 2200 achieved good analytical performances and proved to be a useful method for monitoring and diagnosing SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ramos-Casals, M., Campoamor, M. T., Chamorro, A., Salvador, G., Segura, S., Botero, J. C., Yagüe, J., Cervera, R., Ingelmo, M., & Font, J. (2004) · Lupus · doi:10.1191/0961203304lu1080oa · Cited by 91 · cited 1×
“Increased levels of antidsDNA antibodies detected by Farr assay associated with a decrease of CH50, C3 and C4 measurement was previously described as an indicator of disease activity [22,23].”
BackgroundLópez-Hoyos, M., Cabeza, R., Martínez-Taboada, V. M., Crespo, J., SanSegundo, D., Blanco, R., López-Escribano, H., Peña, M., & Rodríguez-Valverde, V (2005) · Lupus · doi:10.1191/0961203305lu2130oa · Cited by 27
Cited by
ANA screening: an old test with new recommendations
Meroni, P. L., & Schur, P. H. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.127100 · Cited by 533
Shang, X., Ren, L., Sun, G., Yu, T., Yao, Y., Wang, L., Liu, F., Zhang, L., He, X., & Liu, M. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.401 · Cited by 51
Infantino, M., Meacci, F., Bentow, C., Martis, P., Benucci, M., Afeltra, A., Rigon, A., Atzeni, F., Sarzi-Puttini, P., Manfredi, M., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/902821 · Cited by 41
Bentow, C., Lakos, G., Martis, P., Wahl, E., Garcia, M., Viñas, O., Espinosa, G., Cervera, R., Sjöwall, C., Carmona-Fernandes, D., et al. (2016) · Lupus · doi:10.1177/0961203316640917 · Cited by 37
Laboratory evaluation of anti-dsDNA antibodies.
Cockx, M., Van Hoovels, L., De Langhe, E., Lenaerts, J., Thevissen, K., Persy, B., Bonroy, C., Vercammen, M., & Bossuyt, X. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.12.029 · Cited by 30
Metadata
- Authors
- Bardin, N., Desplat-Jego, S., Daniel, L., Jourde Chiche, N., & Sanmarco, M.
- Venue
- Autoimmunity
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 42
- Issue
- 1
- Pages
- 63-68
- ISSN
- 0891-6934 (ISSN-L)
- 1607-842X
- OpenAlex
- W2041087331
- Cited by
- 32
- References
- 2
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BioPlex™ 2200 multiplexed system: Simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. https://app.cochat.ai/papers/10.1080/08916930802354906
- The paper
- Bardin, N., Desplat-Jego, S., Daniel, L., Jourde Chiche, N., & Sanmarco, M. (2009). BioPlex™ 2200 multiplexed system: Simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Autoimmunity. https://doi.org/10.1080/08916930802354906
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.